Amicus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Net Income	-151.58	-236.57	-250.46	-276.85	-356.39	-349	-284	-200.04	-132.12	-68.93	Upgrade
Depreciation & Amortization	7.87	5.34	6.21	8.85	4.78	4.22	3.59	3.24	1.83	1.55	Upgrade
Share-Based Compensation	86.08	76.51	57.84	49.15	44.43	29.26	23.1	17.5	9.97	6.01	Upgrade
Other Operating Activities	-11.46	-11.86	-16.08	-14.44	56.77	15.56	43.61	29.15	20.17	9.7	Upgrade
Operating Cash Flow	-69.09	-166.58	-202.49	-233.29	-250.42	-299.96	-213.7	-150.15	-100.14	-51.67	Upgrade
Capital Expenditures	-7.44	-0.36	-3.88	-3.23	-20.01	-6.31	-4.53	-5.95	-4.82	-0.24	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	-141.06	0	Upgrade
Change in Investments	105.5	92.67	82.65	-10.35	115.17	-114.89	-166.72	1.44	0.53	-106.84	Upgrade
Investing Cash Flow	98.06	92.32	78.76	-13.58	95.15	-121.2	-171.24	-4.51	-145.34	-107.08	Upgrade
Share Issuance / Repurchase	103.21	4.31	229.21	32.25	201.28	304.51	257.74	98.82	256.18	139.48	Upgrade
Debt Issued / Paid	-20.96	-0.28	-0.48	230.6	-0.42	146.26	-0.31	192.34	34.71	-0.3	Upgrade
Other Financing Activities	-20.57	-11.49	-16.66	-	16.64	-	-10	-18.45	-	-	Upgrade
Financing Cash Flow	61.68	-7.46	212.07	262.86	217.5	450.78	247.43	272.72	290.89	139.18	Upgrade
Exchange Rate Effect	6.31	-14.62	-5.05	3.83	1.73	1.52	1.33	-0.13	0	0	Upgrade
Net Cash Flow	96.96	-96.34	83.29	19.82	63.97	31.14	-136.18	117.93	45.41	-19.57	Upgrade
Free Cash Flow	-76.53	-166.93	-206.38	-236.52	-270.43	-306.26	-218.22	-156.1	-104.96	-51.91	Upgrade
Free Cash Flow Margin	-19.16%	-50.70%	-67.55%	-90.66%	-148.39%	-335.65%	-590.90%	-3148.41%	-	-4240.77%	Upgrade
Free Cash Flow Per Share	-0.26	-0.58	-0.76	-0.91	-1.13	-1.65	-1.42	-1.16	-0.95	-0.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).